Subscribe
to get our
LATEST NEWS
Related Posts
Leadership, Trends & Investments
Where Strategy Meets Science: Inside Proventa International’s Life Science Roundtables
Proventa International’s expert curation of strategy meetings is quietly shaping the future of biotech and pharma, one roundtable at a time.
Leadership, Trends & Investments
Bridging Lab, Clinic, and Supply: The New Era of Pharma Operations
No More Silos: Integrating Science and Supply In a pharmaceutical landscape transformed by pandemics and personalized medicine, the walls between lab research, clinical trials, and logistics are coming down. A decade ago, teams handling Chemistry, Manufacturing, and Controls (CMC) focused on producing compounds after clinical success, while clinical operations (ClinOps) ran trials largely in isolation. […]
Leadership, Trends & Investments
Chemists, Code, and Cures: The New Era of Drug Discovery
The Evolving Landscape of Drug Discovery In a gleaming pharmaceutical lab in 2025, a medicinal chemist might spend the morning reviewing molecular designs suggested by an artificial intelligence and the afternoon discussing genetic screen results with a biologist. The search for new medicines has evolved into a high-tech endeavor that would have seemed like science […]
Interviews
Setting the Benchmark: Shaping Analytical Standards to Accelerate Global Convergence in Biologics Quality Systems with Stephan Krause, Bristol Myers Squibb
About the Interviewee Stephan O. Krause is the Executive Director of Cell Therapy Global Quality of Bristol Myers Squibb. Stephan O. Krause, Ph.D., serves as Executive Director for Analytical Science and Technology in Cell Therapy Quality at Bristol Myers Squibb, where he leads global analytical and quality functions supporting the development, manufacture, and regulatory advancement […]
Read More Articles
Leadership, Trends & Investments
Where Strategy Meets Science: Inside Proventa International’s Life Science Roundtables
Proventa International’s expert curation of strategy meetings is quietly shaping the future of biotech and pharma, one roundtable at a time.
Leadership, Trends & Investments
Bridging Lab, Clinic, and Supply: The New Era of Pharma Operations
No More Silos: Integrating Science and Supply In a pharmaceutical landscape transformed by pandemics and personalized medicine, the walls between lab research, clinical trials, and logistics are coming down. A decade ago, teams handling Chemistry, Manufacturing, and Controls (CMC) focused on producing compounds after clinical success, while clinical operations (ClinOps) ran trials largely in isolation. […]
Leadership, Trends & Investments
Chemists, Code, and Cures: The New Era of Drug Discovery
The Evolving Landscape of Drug Discovery In a gleaming pharmaceutical lab in 2025, a medicinal chemist might spend the morning reviewing molecular designs suggested by an artificial intelligence and the afternoon discussing genetic screen results with a biologist. The search for new medicines has evolved into a high-tech endeavor that would have seemed like science […]
Interviews
Setting the Benchmark: Shaping Analytical Standards to Accelerate Global Convergence in Biologics Quality Systems with Stephan Krause, Bristol Myers Squibb
About the Interviewee Stephan O. Krause is the Executive Director of Cell Therapy Global Quality of Bristol Myers Squibb. Stephan O. Krause, Ph.D., serves as Executive Director for Analytical Science and Technology in Cell Therapy Quality at Bristol Myers Squibb, where he leads global analytical and quality functions supporting the development, manufacture, and regulatory advancement […]
Interviews
Harmonizing Biologics Transfer: Global Regulatory Strategy, Compliance Best Practices, and Operational Alignment with Gopi Vudathala, Incyte Corporation
About the Interviewee Gopi Vudathala is the Global Head of Regulatory Affairs and Chemistry, Manufacturing and Controls at Incyte Corporation. Gopi Vudathala, Ph.D., serves as the Global Head of Regulatory Affairs and Chemistry, Manufacturing and Controls (CMC) at Incyte Corporation, a biopharmaceutical company dedicated to the discovery, development, and commercialization of proprietary therapeutics across oncology […]
Interviews
Redefining the Analytical Frontiers of Peptide Science: Innovations Shaping the Next Generation of Therapeutics with Johan Evenäs, RG Discovery
About the Interviewee Johan Evenäs is the Chief Executive Officer at RG Discovery. Johan Evenäs, Ph.D., serves as the Chief Executive Officer of RG Discovery, a life sciences company based in Lund, Sweden, specializing in drug discovery solutions including medicinal chemistry, fragment-based lead discovery, and advanced analytical services. Dr. Evenäs holds an M.Sc. in Chemical […]
Interviews
Toward Industrial Impact: Scaling the Strategic Vision for Bioprocessing Excellence with Greg Papastoitsis, Ankyra Therapeutics
About the Interviewee Gregory Zarbis-Papastoitsis is the Chief Process and Manufacturing Officer at Ankyra Therapeutics. Gregory Zarbis-Papastoitsis, Ph.D., serves as the Chief Process and Manufacturing Officer at Ankyra Therapeutics, an immuno-oncology company advancing novel intratumoral anchored cytokines currently in Phase 1 clinical trials. Dr. Zarbis-Papastoitsis holds a B.S. and Ph.D. in Biochemistry from Binghamton University, […]
Interviews
Enhancing Analytical Method Development: Supporting Cohesive CMC Integration Across Drug Lifecycle Management with Seshu Tyagarajan, Candel Therapeutics
About the Interviewee Seshu Tyagaran is the Chief Technical and Development Officer at Candel Therapeutics. Seshu Tyagarajan, Ph.D., serves as the Chief Technical and Development Officer at Candel Therapeutics, where she leads global technical operations across chemistry, manufacturing, and controls (CMC), driving the clinical and commercial advancement of novel oncolytic viral immunotherapies. With over two […]